The medical-technology company
Medtronic
grabbed an upgrade from
Wells Fargo
on Monday, helping push shares higher.
Analysts led by Larry Biegelsen raised their target for the stock price to $100 from $77 previously, changing their rating to Overweight from Equal Weight. They said the general medtech market is improving and that Medtronic’s (ticker: MDT) own pipeline of products is maturing. U.S. approval of the company’s 708G insulin delivery system is a “major milestone,” Wells Fargo said in a research report.
Source: https://www.barrons.com/articles/medtronic-upgrade-wells-fargo-stock-rising-8fc255d0?siteid=yhoof2&yptr=yahoo